Discovery of Benzenesulfonamides with Potent Human Carbonic Anhydrase Inhibitory and Effective Anticonvulsant Action: Design, Synthesis, and Pharmacological Assessment.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2017-03-14

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/acs.jmedchem.6b01804PMID 28253618
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Advances in structure-based drug discovery of carbonic anhydrase inhibitors

  2017cited by this paper
• Design, synthesis, in-silico and biological evaluation of novel donepezil derivatives as multi-target-directed ligands for the treatment of Alzheimer's disease.

  2017cited by this paper
• Design, synthesis and evaluation of novel indandione derivatives as multifunctional agents with cholinesterase inhibition, anti-β-amyloid aggregation, antioxidant and neuroprotection properties against Alzheimer's disease.

  2016cited by this paper
• Kinetic and X-ray crystallographic investigations of substituted 2-thio-6-oxo-1,6-dihydropyrimidine-benzenesulfonamides acting as carbonic anhydrase inhibitors.

  2016cited by this paper
• Synthesis and carbonic anhydrase inhibitory activities of new thienyl-substituted pyrazoline benzenesulfonamides

  2016cited by this paper
• Kinetic and X-ray crystallographic investigations on carbonic anhydrase isoforms I, II, IX and XII of a thioureido analog of SLC-0111.

  2016cited by this paper
• Isoform-selective inhibitory profile of 2-imidazoline-substituted benzene sulfonamides against a panel of human carbonic anhydrases

  2016cited by this paper
• Design, synthesis and biological evaluation of N-(5-methyl-isoxazol-3-yl/1,3,4-thiadiazol-2-yl)-4-(3-substitutedphenylureido) benzenesulfonamides as human carbonic anhydrase isoenzymes I, II, VII and XII inhibitors

  2016cited by this paper
• Polypharmacological Drugs in the Treatment of Epilepsy: The Comprehensive Review of Marketed and New Emerging Molecules.

  2016cited by this paper
• The anticonvulsant sulfamide JNJ-26990990 and its S,S-dioxide analog strongly inhibit carbonic anhydrases: solution and X-ray crystallographic studies.

  2016cited by this paper
• Amido/ureidosubstituted benzenesulfonamides-isatin conjugates as low nanomolar/subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform XII.

  2016cited by this paper
• Synthesis 4-[2-(2-mercapto-4-oxo-4H-quinazolin-3-yl)-ethyl]-benzenesulfonamides with subnanomolar carbonic anhydrase II and XII inhibitory properties.

  2016cited by this paper
• Synthesis and bioactivity studies on new 4-(3-(4-Substitutedphenyl)-3a,4-dihydro-3H-indeno[1,2-c]pyrazol-2-yl) benzenesulfonamides

  2016cited by this paper
• Synthesis of 4-(thiazol-2-ylamino)-benzenesulfonamides with carbonic anhydrase I, II and IX inhibitory activity and cytotoxic effects against breast cancer cell lines.

  2016cited by this paper
• Design and synthesis of some new 1-phenyl-3/4-[4-(aryl/heteroaryl/alkyl-piperazine1-yl)-phenyl-ureas as potent anticonvulsant and antidepressant agents

  2016cited by this paper
• Structure and function of carbonic anhydrases.

  2016cited by this paper
• 4-Arylbenzenesulfonamides as Human Carbonic Anhydrase Inhibitors (hCAIs): Synthesis by Pd Nanocatalyst-Mediated Suzuki-Miyaura Reaction, Enzyme Inhibition, and X-ray Crystallographic Studies.

  2016cited by this paper
• Pharmacological evaluation of novel 1-[4-(4-benzo[1,3]dioxol-5-ylmethyl-piperazin-1-yl)-phenyl]-3-phenyl-urea as potent anticonvulsant and antidepressant agent

  2016cited by this paper
• Drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors

  2016cited by this paper
• How many carbonic anhydrase inhibition mechanisms exist?

  2016cited by this paper
• Crystal structure of the most catalytically effective carbonic anhydrase enzyme known, SazCA from the thermophilic bacterium Sulfurihydrogenibium azorense.

  2015cited by this paper
• Piperazine scaffold: A remarkable tool in generation of diverse pharmacological agents.

  2015cited by this paper
• Phosphate Chemical Probes Designed for Location Specific Inhibition of Intracellular Carbonic Anhydrases.

  2015cited by this paper
• Discovery of 1,1'-Biphenyl-4-sulfonamides as a New Class of Potent and Selective Carbonic Anhydrase XIV Inhibitors.

  2015cited by this paper
• Synthesis of sulfonamides incorporating piperazinyl-ureido moieties and their carbonic anhydrase I, II, IX and XII inhibitory activity.

  2015cited by this paper
• Design, synthesis and pharmacological evaluation of N-[4-(4-(alkyl/aryl/heteroaryl)-piperazin-1-yl)-phenyl]-carbamic acid ethyl ester derivatives as novel anticonvulsant agents.

  2015cited by this paper
• A Class of 4-Sulfamoylphenyl-ω-aminoalkyl Ethers with Effective Carbonic Anhydrase Inhibitory Action and Antiglaucoma Effects

  2014cited by this paper
• Carbonic anhydrases and brain pH in the control of neuronal excitability.

  2014cited by this paper
• Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.

  2013cited by this paper
• Antiobesity carbonic anhydrase inhibitors: a literature and patent review

  2013cited by this paper
• Carbonic anhydrase regulation and CO(2) sensing in the fungal pathogen Candida glabrata involves a novel Rca1p ortholog.

  2013cited by this paper
• Structural annotation of human carbonic anhydrases

  2013cited by this paper
• Effect of sulfonamides as carbonic anhydrase VA and VB inhibitors on mitochondrial metabolic energy conversion.

  2013cited by this paper
• Diuretics with carbonic anhydrase inhibitory action: a patent and literature review (2005 – 2013)

  2013cited by this paper
• X-ray structure of the first `extremo-α-carbonic anhydrase', a dimeric enzyme from the thermophilic bacterium Sulfurihydrogenibium yellowstonense YO3AOP1.

  2013cited by this paper
• 5-Substituted-(1,2,3-triazol-4-yl)thiophene-2-sulfonamides strongly inhibit human carbonic anhydrases I, II, IX and XII: solution and X-ray crystallographic studies.

  2013cited by this paper
• Antiglaucoma carbonic anhydrase inhibitors: a patent review

  2013cited by this paper
• Carbonic anhydrases: from biomedical applications of the inhibitors and activators to biotechnological use for CO2 capture

  2013cited by this paper
• Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors

  2013cited by this paper
• Anticonvulsant/antiepileptic carbonic anhydrase inhibitors: a patent review

  2013cited by this paper
• Neuronal carbonic anhydrase VII provides GABAergic excitatory drive to exacerbate febrile seizures

  2013cited by this paper
• Inhibition of tumor-associated human carbonic anhydrase isozymes IX and XII by a new class of substituted-phenylacetamido aromatic sulfonamides.

  2013cited by this paper
• Root Effect Hemoglobin May Have Evolved to Enhance General Tissue Oxygen Delivery

  2013cited by this paper
• Update on carbonic anhydrase inhibitors: a patent review (2008 – 2011)

  2012cited by this paper
• Novel therapies for glaucoma: a patent review 2007 – 2011

  2012cited by this paper
• Structure-based drug discovery of carbonic anhydrase inhibitors

  2012cited by this paper
• A new approach to antiglaucoma drugs: carbonic anhydrase inhibitors with or without NO donating moieties. Mechanism of action and preliminary pharmacology

  2012cited by this paper
• Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?

  2012cited by this paper
• Anticonvulsant 4-aminobenzenesulfonamide derivatives with branched-alkylamide moieties: X-ray crystallography and inhibition studies of human carbonic anhydrase isoforms I, II, VII, and XIV.

  2011cited by this paper
• Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors.

  2011cited by this paper
• Carbonic anhydrase inhibitors. Regioselective synthesis of novel 1-substituted 1,4-dihydro-4-oxo-3-pyridinesulfonamides and their inhibition of the human cytosolic isozymes I and II and transmembrane cancer-associated isozymes IX and XII.

  2011cited by this paper
• Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis.

  2011cited by this paper
• Interfering with pH regulation in tumours as a therapeutic strategy

  2011cited by this paper
• Molecular targets for antiepileptic drug development

  2011cited by this paper
• Carbonic anhydrase inhibitors: synthesis and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with 4-substituted 3-pyridinesulfonamides.

  2010cited by this paper
• Sensors and regulators of intracellular pH

  2010cited by this paper
• Spontaneous Network Events Driven by Depolarizing GABA Action in Neonatal Hippocampal Slices are Not Attributable to Deficient Mitochondrial Energy Metabolism

  2010cited by this paper
• Selective hydrophobic pocket binding observed within the carbonic anhydrase II active site accommodate different 4-substituted-ureido-benzenesulfonamides and correlate to inhibitor potency.

  2010cited by this paper
• The maximal electroshock seizure (MES) model in the preclinical assessment of potential new antiepileptic drugs.

  2009cited by this paper
• Which Carbonic Anhydrases are Targeted by the Antiepileptic Sulfonamides and Sulfamates?

  2009cited by this paper
• Carbonic anhydrase inhibitors. Synthesis of 2,4,6-trimethylpyridinium derivatives of 2-(hydrazinocarbonyl)-3-aryl-1H-indole-5-sulfonamides acting as potent inhibitors of the tumor-associated isoform IX and XII.

  2009cited by this paper
• Sildenafil is a strong activator of mammalian carbonic anhydrase isoforms I-XIV.

  2009cited by this paper
• Inhibition of carbonic anhydrases with glycosyltriazole benzene sulfonamides.

  2008cited by this paper
• Structure and inhibition of the CO2-sensing carbonic anhydrase Can2 from the pathogenic fungus Cryptococcus neoformans.

  2008cited by this paper
• Structure and metal exchange in the cadmium carbonic anhydrase of marine diatoms

  2008cited by this paper
• Indanesulfonamides as carbonic anhydrase inhibitors and anticonvulsant agents: structure-activity relationship and pharmacological evaluation.

  2008cited by this paper
• Carbonic anhydrases: novel therapeutic applications for inhibitors and activators

  2008cited by this paper
• Anticonvulsant sulfonamides/sulfamates/sulfamides with carbonic anhydrase inhibitory activity: drug design and mechanism of action.

  2008cited by this paper
• Carbonic anhydrase inhibitors as anticonvulsant agents.

  2007cited by this paper
• Control of hypothalamic orexin neurons by acid and CO2

  2007cited by this paper
• Expression of carbonic anhydrases II, IV, VII, VIII and XII in rat brain after kainic acid induced status epilepticus.

  2006cited by this paper
• Molecular targets versus models for new antiepileptic drug discovery.

  2006cited by this paper
• Epileptic Seizures and Epilepsy: Definitions Proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)

  2005cited by this paper
• Two developmental switches in GABAergic signalling: the K+–Cl− cotransporter KCC2 and carbonic anhydrase CAVII

  2005cited by this paper
• Carbonic anhydrase inhibitors. Novel sulfanilamide/acetazolamide derivatives obtained by the tail approach and their interaction with the cytosolic isozymes I and II, and the tumor-associated isozyme IX.

  2005cited by this paper
• Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs?

  2005cited by this paper
• Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides.

  2005cited by this paper
• Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors.

  2005cited by this paper
• Topiramate modulates pH of hippocampal CA3 neurons by combined effects on carbonic anhydrase and Cl−/HCO3− exchange

  2004cited by this paper
• Carbonic anhydrase inhibitors: aromatic and heterocyclic sulfonamides incorporating adamantyl moieties with strong anticonvulsant activity.

  2004cited by this paper
• Carbonic anhydrase inhibitors: the first on-resin screening of a 4-sulfamoylphenylthiourea library.

  2004cited by this paper
• Zonisamide: chemistry, mechanism of action, and pharmacokinetics.

  2004cited by this paper
• Carbonic Anhydrase Isoform VII Acts as a Molecular Switch in the Development of Synchronous Gamma-Frequency Firing of Hippocampal CA1 Pyramidal Cells

  2004cited by this paper
• Regulation and modulation of pH in the brain.

  2003cited by this paper
• Carbonic anhydrase inhibitors.

  2003cited by this paper
• Carbonic anhydrase inhibitors: SAR and X-ray crystallographic study for the interaction of sugar sulfamates/sulfamides with isozymes I, II and IV.

  2003cited by this paper
• Carbonic anhydrase inhibitors. Inhibition of tumor-associated isozyme IX by halogenosulfanilamide and halogenophenylaminobenzolamide derivatives.

  2003cited by this paper
• Effects of antiepileptic drugs on extracellular pH regulation in the hippocampal CA1 region in vivo.

  2002cited by this paper
• Two new actions of topiramate: inhibition of depolarizing GABA(A)-mediated responses and activation of a potassium conductance.

  2002cited by this paper
• Long-term effectiveness and side effects of acetazolamide as an adjunct to other anticonvulsants in the treatment of refractory epilepsies.

  2002cited by this paper
• Pentylenetetrazole-induced inhibition of recombinant gamma-aminobutyric acid type A (GABA(A)) receptors: mechanism and site of action.

  2001cited by this paper
• Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V).

  2001cited by this paper
• Pentylenetetrazole-Induced Inhibition of Recombinant γ-Aminobutyric Acid Type A (GABAA) Receptors: Mechanism and Site of Action

  2001cited by this paper
• An overview of the distribution and function of carbonic anhydrase in mammals.

  2000cited by this paper
• Carbonic anhydrase inhibitors: topical sulfonamide antiglaucoma agents incorporating secondary amine moieties.

  2000cited by this paper
• Arylsulfonyl-N,N-diethyl-dithiocarbamates: a novel class of antitumor agents.

  2000cited by this paper
• Carbonic anhydrase inhibitors: water-soluble 4-sulfamoylphenylthioureas as topical intraocular pressure-lowering agents with long-lasting effects.

  2000cited by this paper
• Carbonic anhydrase inhibitors: sulfonamides incorporating furan-, thiophene- and pyrrole-carboxamido groups possess strong topical intraocular pressure lowering properties as aqueous suspensions.

  2000cited by this paper
• Activity-Dependent Intracellular Acidification Correlates with the Duration of Seizure Activity

  2000cited by this paper
• Carbonic anhydrase inhibitors: synthesis of N-morpholylthiocarbonylsulfenylamino aromatic/heterocyclic sulfonamides and their interaction with isozymes I, II and IV.

  2000cited by this paper

• Discovery of new thiazolidin-4-one and thiazole nucleus incorporation sulfaguanidine scaffold as new class of antimicrobial agents: Design, synthesis, in silico ADMET, and docking simulation

  2025cites this paper
• Quality by design-based method to synthesize sulfonamides using LiOH.H2O

  2025cites this paper
• Discovery and characterization of phenoxyacetic acid derivatives as potential antiepileptic agents

  2025cites this paper
• Identification of Novel Triazole-Pyrazole Conjugates as Potential Anticonvulsant Agents: Synthesis and Biological Evaluations.

  2025cites this paper
• Identification of Benzenesulfonamide-Containing Thiazolidine-2,4-Dione Derivatives as Novel Carbonic Anhydrase II and VII Inhibitors with Anti-Epileptic Activity.

  2025cites this paper
• Comprehensive Insights Into Sulfanilamido‐Based Medicinal Design and Research

  2025cites this paper
• Synthesis and Characterization of New Ureido‐Containing Benzenesulfonamide Derivatives and Their Inhibition Effects on Carbonic Anhydrase Isoforms I, II, IX, and XII

  2025cites this paper
• Development of isatin-functionalized benzenesulfonamides as novel carbonic anhydrase II and VII inhibitors with antiepileptic potential.

  2025cites this paper
• Shooting an Arrow against Convulsion: Novel Triazole-Grafted Benzenesulfonamide Derivatives as Carbonic Anhydrase II and VII Inhibitors.

  2025cites this paper
• A new framework for novel analogues of pazopanib as potent and selective human carbonic anhydrase inhibitors: Design, repurposing rational, synthesis, crystallographic, in vivo and in vitro biological assessments.

  2024cites this paper
• Current development in sulfonamide derivatives to enable CNS-drug discovery.

  2024cites this paper
• Multiple Binding Modes of Inhibitors to Human Carbonic Anhydrases: An Update on the Design of Isoform-Specific Modulators of Activity.

  2024cites this paper
• Thia‐ and Seleno‐Michael Reactions for the Synthesis of Carbonic Anhydrases Inhibitors

  2024cites this paper
• Chemistry of heterocycles as carbonic anhydrase inhibitors: A pathway to novel research in medicinal chemistry review

  2024cites this paper
• Multitarget action of Benzothiazole-piperazine small hybrid molecule against Alzheimer's disease: In silico, In vitro, and In vivo investigation.

  2024cites this paper
• Mono- and three-tailed sugar and iminosugar decorated benzenesulfonamide carbonic anhydrase inhibitors.

  2023cites this paper
• Advances in Epilepsy: Mechanisms, Clinical Trials, and Drug Therapies.

  2023cites this paper
• Design, synthesis, and carbonic anhydrase inhibition activities of Schiff bases incorporating benzenesulfonamide scaffold: Molecular docking application

  2023cites this paper
• Novel beta-lactam substituted benzenesulfonamides: in vitro enzyme inhibition, cytotoxic activity and in silico interactions

  2023cites this paper
• Metalloenzyme-mediated thiol-yne addition towards photoisomerizable fluorescent dyes.

  2022cites this paper
• Revealing the Antiepileptic Effect of α-Asaronol on Pentylenetetrazole-Induced Seizure Rats Using NMR-Based Metabolomics

  2022cites this paper
• Carbonic Anhydrases in Metazoan Model Organisms: Molecules, Mechanisms, and Physiology.

  2022cites this paper
• Identification of Guaifenesin-Andrographolide as a Novel Combinatorial Drug Therapy for Epilepsy Using Network Virtual Screening and Experimental Validation.

  2022cites this paper
• Benzenesulfonamides with trisubstituted triazole motif as selective carbonic anhydrase I, II, IV, and IX inhibitors

  2022cites this paper
• Development of benzene and benzothiazole-sulfonamide analogues as selective inhibitors of the tumor-associated carbonic anhydrase IX.

  2022cites this paper
• Identification of New Carbonic Anhydrase VII Inhibitors by Structure-Based Virtual Screening

  2022cites this paper
• Anti-breast cancer action of carbonic anhydrase IX inhibitor 4-[4-(4-Benzo[1,3]dioxol-5-ylmethyl-piperazin-1-yl)-benzylidene-hydrazinocarbonyl]-benzenesulfonamide (BSM-0004): in vitro and in vivo studies

  2021cites this paper
• The crystal structures of 2-(4-benzhydrylpiperazin-1-yl)-N-(4-sulfamoylphenyl)acetamide in complex with human carbonic anhydrase II and VII provide insights into selective CA inhibitor development

  2021cites this paper
• Discovery of Potent Carbonic Anhydrase Inhibitors as Effective Anticonvulsant Agents: Drug Design, Synthesis, and In Vitro and In Vivo Investigations.

  2021cites this paper
• Anti-inflammatory Effects of S. cumini Seed Extract on Gelatinase-B (MMP-9) Regulation against Hyperglycemic Cardiomyocyte Stress

  2021cites this paper
• 3-Benzoylquinoxalinone as a photoaffinity labelling derivative with fluorogenic properties allowing reaction monitoring under "no-wash" conditions.

  2021cites this paper
• Synthesis of Azasugar–Sulfonamide conjugates and their Evaluation as Inhibitors of Carbonic Anhydrases: the Azasugar Approach to Selectivity

  2021cites this paper
• New hydronaphthalene-sulfonamide derivatives: Synthesis, antimicrobial evaluation and QSAR study

  2021cites this paper
• Brønsted Acid Promoted N ‐Dealkylation of N ‐Alkyl(sulfon)amides

  2021cites this paper
• Carbonic Anhydrase Inhibitors and Epilepsy: State of the Art and Future Perspectives

  2021cites this paper
• In vitro and in silico evaluation of N-(alkyl/aryl)-2-chloro-4-nitro-5- [(4-nitrophenyl)sulfamoyl]benzamide derivatives for antidiabetic potential using docking and molecular dynamic simulations

  2020cites this paper
• Synthesis of sulfonamide and their synthetic and therapeutic applications: Recent advances

  2020cites this paper
• Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: Where are we today?

  2020influential citation
• Development of novel N-(6-methanesulfonyl-benzothiazol-2-yl)-3-(4-substituted-piperazin-1-yl)-propionamides with cholinesterase inhibition, anti-β-amyloid aggregation, neuroprotection and cognition enhancing properties for the therapy of Alzheimer's disease

  2020cites this paper
• Novel Indole-Based Hydrazones as Potent Inhibitors of the α-class Carbonic Anhydrase from Pathogenic Bacterium Vibrio cholerae

  2020cites this paper
• Benzofuran-Based Carboxylic Acids as Carbonic Anhydrase Inhibitors and Antiproliferative Agents against Breast Cancer.

  2020cites this paper
• Conformational changes in alkyl chains determine the thermodynamic and kinetic binding profiles of Carbonic Anhydrase inhibitors.

  2020cites this paper
• Synthesis and anti-inflammatory activity of sulfonamides and carboxylates incorporating trimellitimides: Dual cyclooxygenase/carbonic anhydrase inhibitory actions.

  2019cites this paper
• 2,4-Dichloro-5-[(N-aryl/alkyl)sulfamoyl]benzoic Acid Derivatives: In Vitro Antidiabetic Activity, Molecular Modeling and In silico ADMET Screening.

  2019cites this paper
• Novel benzofuran-based sulphonamides as selective carbonic anhydrases IX and XII inhibitors: synthesis and in vitro biological evaluation

  2019cites this paper
• Sulfonamides incorporating piperazine bioisosteres as potent human carbonic anhydrase I, II, IV and IX inhibitors.

  2019cites this paper
• Syntesis of thio- and seleno-acetamides bearing benzenesulfonamide as potent inhibitors of human carbonic anhydrase II and XII.

  2019cites this paper
• Synthesis of benzensulfonamides linked to quinazoline scaffolds as novel carbonic anhydrase inhibitors.

  2019cites this paper
• Sulfonamide-Derived Four-Component Molecular Hybrids as Novel DNA-Targeting Membrane Active Potentiators against Clinical Escherichia coli.

  2019cites this paper
• Discovery of Benzenesulfonamide Derivatives as Carbonic Anhydrase Inhibitors with Effective Anticonvulsant Action: Design, Synthesis, and Pharmacological Evaluation.

  2018cites this paper
• Synthesis of different thio-scaffolds bearing sulfonamide with subnanomolar carbonic anhydrase II and IX inhibitory properties and X-ray investigations for their inhibitory mechanism.

  2018cites this paper
• Discovery of potent anti-convulsant carbonic anhydrase inhibitors: Design, synthesis, in vitro and in vivo appraisal.

  2018cites this paper
• The anti-epileptogenic and cognition enhancing effect of novel 1-[4-(4-benzo [1, 3] dioxol-5-ylmethyl-piperazin-1-yl)-phenyl]-3-phenyl-urea (BPPU) in pentylenetetrazole induced chronic rat model of epilepsy.

  2018cites this paper
• Design, Synthesis, and X-ray of Selenides as New Class of Agents for Prevention of Diabetic Cerebrovascular Pathology.

  2018cites this paper
• Design, synthesis and X-ray crystallography of selenides bearing benzenesulfonamide moiety with neuropathic pain modulating effects.

  2018cites this paper
• Discovery of novel Methylsulfonyl phenyl derivatives as potent human Cyclooxygenase-2 inhibitors with effective anticonvulsant action: Design, synthesis, in-silico, in-vitro and in-vivo evaluation.

  2018cites this paper
• Synthesis of Novel Selenides Bearing Benzenesulfonamide Moieties as Carbonic Anhydrase I, II, IV, VII, and IX Inhibitors.

  2017cites this paper
• Acyl selenoureido benzensulfonamides show potent inhibitory activity against carbonic anhydrases from the pathogenic bacterium Vibrio cholerae.

  2017cites this paper
• Crystal structure of the human carbonic anhydrase II adduct with 1-(4-sulfamoylphenyl-ethyl)-2,4,6-triphenylpyridinium perchlorate, a membrane-impermeant, isoform selective inhibitor

  2017cites this paper
• Development of sulfonamides incorporating phenylacrylamido functionalities as carbonic anhydrase isoforms I, II, IX and XII inhibitors.

  2017cites this paper
• Sulphonamide inhibition studies of the β-carbonic anhydrase from the bacterial pathogen Clostridium perfringens

  2017cites this paper